ASH Submits Comments to NHLBI on its Draft Strategic Research Priorities
ASH submitted comments to the National Heart, Lung and Blood Institute (NHLBI) on its recently released draft strategic research priorities that will inform the Institute’s policy and funding decisions for the next several years. ASH’s comments were developed based on the ASH Agenda for Hematology Research and input from members of the ASH Committee on Scientific Affairs and ASH Scientific Committees. ASH strongly supports the NHLBI’s vision and is pleased to see many priorities in its draft align with the Society’s mission to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic, hemostatic and vascular systems. The Society appreciates the opportunity to provide comments to the NHLBI and looks forward to working with the Institute on implementing its vision.
